Healthcare | May 03, 2025
Thyrocare launches diagnostic lab in Bhagalpur
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
The 27 greenfield labs across the country ensure timely and accurate reporting
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for metastatic breast cancer patients.
Aims to become India’s leading cancer testing company
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Subscribe To Our Newsletter & Stay Updated
